Jatin Shah - 12 Jul 2021 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
EVP, Chief Medical Officer
Signature
/s/ Nancy Smith as Attorney-in-Fact for Jatin Shah
Issuer symbol
KPTI
Transactions as of
12 Jul 2021
Net transactions value
-$6,470
Form type
4
Filing time
13 Jul 2021, 18:21:51 UTC
Previous filing
11 May 2021
Next filing
09 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Tax liability $6,470 -665 -0.5% $9.73* 131,137 12 Jul 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy the reporting person's tax obligation in connection with the vesting of 2,413 restricted stock units on July 11, 2021.